|
| [7aS,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline Basic information |
Product Name: | [7aS,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline | Synonyms: | (+)-Aporrheine;(+)-Isoremerine;(6aS)-1,2-(Methylenebisoxy)-6-methyl-5,6,6aα,7-tetrahydro-4H-dibenzo[de,g]quinoline;[7aS,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline;Aporrheine;Isoremerine;Aporeine;Aporheine | CAS: | 2030-53-7 | MF: | C18H17NO2 | MW: | 279.33 | EINECS: | | Product Categories: | | Mol File: | 2030-53-7.mol | |
| [7aS,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline Chemical Properties |
Melting point | 102° | alpha | D22 +80° (c = 0.50 in ethanol) | Boiling point | 424.0±34.0 °C(Predicted) | density | 1.269±0.06 g/cm3(Predicted) | pka | 6.1(at 25℃) |
| [7aS,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline Usage And Synthesis |
Uses | Aporrheine can be used for topical delivery against skin cancer, and cardioprotective potential on doxorubicin induced cardiotoxicity in rats. It can also be used for alkaloid and terpenoid compounds isolated compounds to treat various infections. |
| [7aS,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline Preparation Products And Raw materials |
|